Hikma Pharmaceuticals PLC (HIK.L)
Makes generic and specialty medicines sold in hospitals and pharmacies worldwide.
1,620.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago-16.5%
The outlook
Hikma Pharmaceuticals trades at 1620p with strong analyst backing—the consensus leans "Strong Buy" with an average price target roughly 15% above current levels. The stock sits comfortably above both its 50- and 200-day moving averages and is positioned mid-range within its 52-week band, reflecting steady upward momentum this year.
What’s behind the score
Analyst consensusStrong Buy — 1.5 avg of 12 analysts
Price trendAbove its 50- & 200-day averages
52-week range53% of the way from its 52-week low to high
Price targetAvg target +15% vs current price
Analyst price target
~12-month · 12 analysts1,866.49average target+15.2% vs now
Now 1,620.00
Low 1,340.15High 2,641.86
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$3.38B
52-wk high
2,004.00
52-wk low
1,187.00
50-day avg
1,508.68
200-day avg
1,493.39
Trailing P/E
11.9